Categories: MedicaidMedicareNews

SpectraMedix Expands Value-Based Payment (VBP) Contract Modeler to Support the Industry’s Most Comprehensive Range of Value-Based Contract Types

Innovative solution simplifies value-based contracting and scenario modeling, fostering sustainable, mutually beneficial arrangements.

EAST WINDSOR, N.J., Jan. 7, 2025 /PRNewswire/ — SpectraMedix, a leader in advanced analytics and technology solutions for value-based payment (VBP) models, announces that its VBP Contract Modeler now supports the broadest portfolio of value-based contracts in the industry. Already utilized by health plans and health systems in over 20 states, this expansion reinforces SpectraMedix’s commitment to driving the adoption of sustainable and impactful value-based contracts.

The enhanced SpectraMedix VBP Contract Modeler enables users to automate the modeling and development of diverse value-based contract models spanning pay-for-quality (P4Q), shared savings, shared risk, and capitation across all lines of business. By streamlining contract design and simulation, SpectraMedix empowers health plans and health systems to test scenarios and explore different risk-sharing and payout structures to construct value-based contracts that align with their unique objectives and drive meaningful results.

“Over the past five years, the SpectraMedix VBP Contract Modeler has become the gold standard for actuaries and contracting teams, enabling health plans and health systems to critically evaluate, develop, and negotiate the next generation of value-based contracts,” said Raj Lakhanpal, MD, CEO of SpectraMedix. “Our solution empowers clients to simulate performance across various contract types and scenarios, helping them build sustainable arrangements that offer the right balance across quality, cost, utilization and risk—ultimately benefiting their providers and the populations they serve.”   

An Integrated Solution for Value-Based Arrangements

The VBP Contract Modeler is seamlessly embedded in the SpectraMedix VBP Platform, providing an all-in-one solution encompassing AI-powered analytics, contract modelling and settlement, and provider enablement tools. This comprehensive solution supports strategic decision-making across commercial, Medicare and Medicaid markets, helping health plans and health systems unlock the full potential of their value-based arrangements. For more information on the SpectraMedix VBP Contract Modeler or the SpectraMedix VBP Platform, visit https://www.spectramedix.com/spectramedix-value-based-platform.

About SpectraMedix

SpectraMedix delivers the complete picture of value-based performance to drive operational excellence and accelerate performance improvement for health plans and health systems across the spectrum of value-based contracts. Our comprehensive, end-to-end platform empowers organizations with transparency into financial performance, quality, risk and utilization to help them establish trust with providers, maximize revenue and scale their value-based arrangements. For more information, visit www.SpectraMedix.com.

Media Contact:

Nathan Brown  
Director of Marketing
388163@email4pr.com
(609) 638-2987

View original content to download multimedia:https://www.prnewswire.com/news-releases/spectramedix-expands-value-based-payment-vbp-contract-modeler-to-support-the-industrys-most-comprehensive-range-of-value-based-contract-types-302343162.html

SOURCE SpectraMedix

Staff

Recent Posts

RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has…

1 hour ago

ITRI Opens CES 2025 With Trend-Leading Showcase and Partnership With Reliance Biotech Corporation

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) initiated its presence…

1 hour ago

NOTICE OF DATA BREACH

LOS ANGELES, Jan. 8, 2025 /PRNewswire/ -- Dear members of the STIIIZY community:  Stiiizy, Inc.…

1 hour ago

Ascent Strategy Group Recognized by Modern Healthcare’s Best in Business, Affirms Health Equity Mission Amid Alarming Disparities

Agency Founder nominated Outstanding Agency Professional, Innovator of the Year First public relations agency built…

1 hour ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options

VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or…

4 hours ago

cbdMD Announces Additional Conversions of Its Convertible Notes

Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

7 hours ago